{"id":503,"date":"2019-05-09T20:29:13","date_gmt":"2019-05-09T20:29:13","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=503"},"modified":"2024-01-22T13:50:39","modified_gmt":"2024-01-22T12:50:39","slug":"programa-de-neurociencies","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-neurociencies\/programa-de-neurociencies\/","title":{"rendered":"Programa de Neuroci\u00e8ncies"},"content":{"rendered":"\n

\n\t\tPrograma de Neuroci\u00e8ncies\n\t<\/h1>\n

\n\t\tResum\n\t<\/h3>\n\t

El Programa estudia una gran varietat de malalties neurol\u00f2giques i psiqui\u00e0triques abastant des dels aspectes moleculars i cel\u00b7lulars fins als cl\u00ednics i amb un fort \u00e8mfasi en la investigaci\u00f3 traslacional. Aix\u00ed doncs, la recerca es centra en el desenvolupament de la medicina experimental, la neuroimatge, la neurofarmacologia, la gen\u00e8tica, neuroci\u00e8ncia cognitiva i les ci\u00e8ncies b\u00e0siques en les \u00e0rees de la neurologia i la\u00a0 salut mental. A la vegada, la implementaci\u00f3 traslacional inclou l’\u00fas de noves eines de diagn\u00f2stic gen\u00e8tic i gen\u00f2mic, el descobriment de noves dianes farmacol\u00f2giques i\u00a0 medicaments, el desenvolupament de biomarcadors, l’estimulaci\u00f3 cerebral, neurorehabilitaci\u00f3 cognitiva i l’\u00fas de c\u00e8l\u00b7lules mare en la regeneraci\u00f3 del teixit nervi\u00f3s. Igualment, ostentar un Banc de Teixits Neurol\u00f2gics de renom nacional i internacional \u00e9s una de les fortaleses genu\u00efnes del Programa. Conseq\u00fcentment, el Programa de Neuroci\u00e8ncies pret\u00e9n contribuir a la conquesta d’una de les \u00faltimes grans fronteres de la ci\u00e8ncia moderna: el coneixement i manipulaci\u00f3 del cervell.<\/p>\n\t\t\t\t\"neuroprogam\"\n\t

L’objectiu del Programa de Neuroci\u00e8ncies de l’IDIBELL \u00e9s entendre el funcionament del cervell, tant en la salut com en la malaltia.<\/p>\n

11<\/h2>\n

Grups<\/h2>\n

57<\/h2>\n

Investigadors principals<\/h2>\n

\n\t\tGrups de Recerca\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"memory_fuentemilla_logo-270x150\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Rodr\u00edguez-Fornells\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tCognici\u00f3 i plasticitat cerebral\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Neurodevelopmental-disorders-s\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Alc\u00e1ntara\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tTrastorns del neurodesenvolupament\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"myelinated_neuron\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Llobet\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tNeurobiologia Cel\u00b7lular i Molecular\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"pnns_at_primary_somatosensory_cortex_in_mouse_brain_03\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Pujol\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMalalties neurometab\u00f2liques\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"206-neurofarmacologiadolor-fciruela-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Ciruela & Aso\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tNeurofarmacologia i Dolor\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"mental_heatlh_1\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Mench\u00f3n & Soriano\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tPsiquiatria i Salut mental\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"208-basescelmoltrastsensorials-jllorens-def\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Llorens\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tBases cel\u00b7lulars i moleculars dels trastorns sensorials\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"pyramidal_hippocampal_neuron_40x\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Mart\u00ednez-Yelamos\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tMalalties Neurol\u00f2giques i Neurogen\u00e8tica\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"grup_sense_foto_-_neuro_7\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Sabat\u00e9 & Colomina\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tFisiopatologia Perioperat\u00f2ria i Dolor\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Stem-cells-and-Neurodegenerative-diseases2\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Consiglio\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tC\u00e8l\u00b7lules mare i malalties neurodegeneratives\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Psychoneurobiology\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Fernandez-Aranda & Jimenez-Murcia\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tPsiconeurobiologia dels Trastorns Alimentaris i Conductes Addictives\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\"Antonio-Martinez-Yelamos22\"\n

\n\t\tMart\u00ednez Yelamos, Antoni\n\t<\/h4>\n

\n\t\tCO-COORDINADOR DE PROGRAMA\n\t<\/h4>\n

\n\t\t\n\t\tamyelamos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Antonella-Consiglio22\"\n

\n\t\tConsiglio, Antonella\n\t<\/h4>\n

\n\t\tCO-COORDINADORA DE PROGRAMA\n\t<\/h4>\n

\n\t\t\n\t\taconsiglio@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tLlobet Berenguer, Artur\n\t<\/h4>\n

\n\t\tCOORDINADOR DOCENT\n\t<\/h4>\n

\n\t\t\n\t\tallobet@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tNot\u00edcies relacionades\n\t<\/h3>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Ministeri de Ci\u00e8ncia i Innovaci\u00f3 atorga 4 milions d’euros per a l’assaig cl\u00ednic de Fase 2b amb un nou f\u00e0rmac per a l’ictus isqu\u00e8mic<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t22\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls aliments ultraprocessats, una de les principals addiccions per als infants d’avui dia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/11\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nou algorisme cl\u00ednic augmenta la taxa de diagn\u00f2stic de les malalties rares<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t08\/09\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tRelacionen la concentraci\u00f3 de dos neurotransmissors amb trastorns de conducta aliment\u00e0ria i obesitat<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t31\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tPrimera avaluaci\u00f3 de l’heterogene\u00eftat cerebral individual en trastorns mentals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn biomarcador d’imatge pot ajudar a comprendre i tractar millor l’esclerosi m\u00faltiple progressiva<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t23\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nou f\u00e0rmac neuroprotector mostra uns bons resultats preliminars per a l’ictus isqu\u00e8mic<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t02\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tInvestigadors d’IDIBELL i CIBER identifiquen una nova malaltia gen\u00e8tica que afecta el desenvolupament del sistema nervi\u00f3s i provoca insufici\u00e8ncia hep\u00e0tica<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t25\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tNova col\u00b7laboraci\u00f3 amb Blue Zone studio per a la creaci\u00f3 d’una aplicaci\u00f3 de monitoratge dels pacients amb TOC<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Fundaci\u00f3 Vela Cl\u00e0ssica d’Espanya dona 20.000 euros per a la recerca de l’ELA<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t14\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"

Programa de Neuroci\u00e8ncies Resum El Programa estudia una gran varietat de malalties neurol\u00f2giques i psiqui\u00e0triques abastant des dels aspectes moleculars i cel\u00b7lulars fins als cl\u00ednics i amb un fort \u00e8mfasi en la investigaci\u00f3 traslacional. Aix\u00ed doncs, la recerca es centra en el desenvolupament de la medicina experimental, la neuroimatge, la neurofarmacologia, la gen\u00e8tica, neuroci\u00e8ncia cognitiva […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":500,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-13 22:01:34","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/503"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=503"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/503\/revisions"}],"predecessor-version":[{"id":24949,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/503\/revisions\/24949"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/500"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}